CD163 and cancer: Interestingly, among pan-cancer, LGG showed the most significant correlation between GLA with CD86 (P=4.52e-27, Figure 5A), CSF1R (P=8.17e-09, Figure 5B),CCL2 (P=3.98e-14, Figure 5C), CD68 (P=2.37e-34, Figure 5D), IL10 (P=3.29e-21, Figure 5E), IRF5 (P=8.5e-25, Figure 6B), CD163 (P=3.8e-26, Figure 6D), VSIG4 (P=9.17e-16, Figure 6E) and MS4A4A (P=1.39e-21, Figure 6F).